Novo Nordisk Broadens Arsenal with Implant Deal and MASH Approval as Buyback Sustains Momentum
Novo Nordisk is fighting back against Eli Lilly’s encroachment on multiple fronts — through a novel long-acting implant…
Browsing Tag